During the 2024–2025 biennium, PAHO played a central role in strengthening health sector governance in Belize by supporting the Ministry of Health and Wellness (MoHW) to develop and operationalize the Health Sector Strategic Plan 2025–2034 and its first results‑based operational plan.
PAHO supported Belize in addressing vaccine hesitancy by empowering Community Health Workers (CHWs) to build trust in immunization services. Through targeted technical cooperation, PAHO assisted the MoHW in designing and implementing training that enhanced CHWs’ technical knowledge on immunization and their communication skills to engage families using culturally appropriate, dialogue‑based approaches.
PAHO supported Belize in tobacco control in line with the internationally accepted strategies through the finalization and tabling of comprehensive tobacco control legislation and the expansion of cessation services.
PAHO supported Belize in advancing mental health reform by strengthening legislation, surveillance, crisis response, and responsible media reporting on suicide and self‑harm. Technical cooperation included developing recommendations to guide updates to mental health legislation in line with international human rights standards, supporting capacity building for police officers and frontline responders for community crisis response, and strengthening implementation of the Mental Health Gap Action Programme (mhGAP).
During the 2024–2025 biennium, PAHO strengthened Belize’s preparedness for pandemic influenza and other high‑impact health emergencies by enhancing climate‑resilient health infrastructure and laboratory capacity. In collaboration with the European Union, PAHO supported the SMART retrofitting and greening of five health facilities and the Central Medical Laboratory (CML), including the installation of solar photovoltaics systems, to improve disaster readiness and ensure continuity of essential services during emergencies.
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 01.b. Number of countries and territories that have implemented strategies to strengthen the response capacity of the first level of care | Target 2025 | Achieved |
| 02.e. Number of countries and territories with capacity to implement and monitor national policies or strategies to improve the health and development of young children that are informed by the WHO/UNICEF framework Nurturing Care for Early Childhood Development | Baseline 2019 | Achieved |
| 08.c. Number of countries that increase the number of units of blood available for transfusion per thousand inhabitants (UBAT) by at least 5% per year to reach the target of 30 UBAT | Target 2025 | Not achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 04.c. Number of countries and territories with at least 95% coverage of syphilis treatment in pregnant women | Target 2025 | Achieved |
| 04.g. Number of countries and territories reporting at least 95% coverage at the national level of the second dose of measles and rubella containing vaccine (MRCV) | Baseline 2019 | Not achieved |
| 04.h. Number of countries and territories reporting at least 95% coverage of 3 doses of diphtheria, pertussis, and tetanus -containing vaccine (DPT3) in 80% of municipalities | Baseline 2019 | Not achieved |
| 04.j. Number of countries and territories that have incorporated HPV vaccines in their national vaccination program | Baseline 2019 | Achieved |
| 12.b. Number of countries and territories where the entire endemic (by vector transmission) territory or territorial unit has a domestic infestation index (by the main triatomine vector species or by the substitute vector, as the case may be) of less than or equal to 1% | Baseline 2019 | Not achieved |
| 12.c. Number of countries and territories with increased antimicrobial resistance (AMR) surveillance capacity to guide the public health interventions for decreasing the risk and preventing the spread of multidrug-resistant infections through intersectoral action | Baseline 2019 | Achieved |
| 17.b. Number of countries and territories with >80% of malaria cases investigated and classified in areas targeted for elimination or prevention of reestablishment | Baseline 2019 | Achieved |
| 17.c [b]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Chagas Disease] | Baseline 2019 | Achieved |
| 17.c [c]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Dog-mediated human rabies] | Baseline 2019 | Partially achieved |
| 17.d. Number of countries and territories with established capacity and effective processes to eliminate human rabies transmitted by dogs | Baseline 2019 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 05.e. Number of countries and territories whose surveillance systems have the capacity to report on key indicators of the Global Monitoring Framework for Noncommunicable Diseases | Baseline 2019 | Partially achieved |
| 05.h. Number of countries and territories that have increased the rate of persons admitted with mental disorders to general hospitals | Baseline 2019 | Achieved |
| 05.i. Number of countries and territories that have increased the rate of persons receiving treatment interventions (pharmacological, psychosocial, and rehabilitation and aftercare services) for substance use disorders in the health service network | Target 2025 | Achieved |
| 13.d. Number of countries and territories that have eliminated industrially produced trans fatty acids | Target 2025 | Not achieved |
| 15.a. Number of countries and territories with an operational advisory committee or lead agency on road safety that supports the development and/or implementation of a national road safety strategy | Baseline 2019 | Achieved |
| 15.b. Number of countries and territories that have a national or multisectoral plan addressing violence that includes the health system | Baseline 2019 | Achieved |
| 16.a. Number of countries and territories with ongoing collaboration between government mental health services and other departments, services, and sectors | Target 2025 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 18.g. Number of countries and territories with capacity to address health in chemical safety (including human health exposure to metals and/or pesticides) | Target 2025 | Achieved |
| 18.h. Number of countries and territories with capacity to address the health-related effects of climate change | Target 2025 | Achieved |
| 26.a. Number of countries and territories with institutional responses and accountability mechanisms that are advancing health equity, gender and ethnic equality in health, and human rights | Target 2025 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 21.b. Number of countries and territories that generate, analyze, and use data and information according to health priorities, disaggregated by geopolitical and demographic strata, as appropriate to the national context | Target 2025 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 23.a. Number of countries and territories that meet or exceed minimum capacities to manage public health risks associated with emergencies | Baseline 2019 | Achieved |
| 23.b. Number of States Parties meeting and sustaining International Health Regulations (IHR) requirements for core capacities | Target 2025 | Achieved |
| 24.a. Number of countries and territories with installed capacity to effectively respond to major epidemics and pandemics | Target 2025 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 27.a. Proportion of countries and territories where the national health authority reports satisfaction with PAHO/WHO’s leading role on global and regional health issues | Target 2025 | Achieved |
| 27.b. Number of countries and territories for which there is alignment between the national health policy, strategy, or plan and the outcomes defined in the PAHO Strategic Plan 2020-2025 | Target 2025 | Achieved |
1. Access to comprehensive and quality health services
2. Health throughout the life course
4. Response capacity for communicable diseases
5. Access to services for NCDs and mental health conditions
8. Access to health technologies
12. Risk factors for communicable diseases
13. Risk factors for noncommunicable diseases
15. Intersectoral response to violence and injuries
16. Intersectoral action on mental health
17. Elimination of communicable diseases
18. Social and environmental determinants
21. Data, information, knowledge, and evidence
23. Health emergencies preparedness and risk reduction
24. Epidemic and pandemic prevention and control
26. CCTs: equity, gender, ethnicity, and human rights
27. Leadership and governance
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 01.1.a. Number of countries and territories with frameworks in place for integrated health service delivery networks (IHSDN) to improve the resolution capacity of the first level of care and integrate priority programs, including NCDs and the elimination agenda | Target 2025 | Achieved |
| 01.2.a. Number of countries and territories implementing strategies and/or plans of action to improve quality of care in health service delivery | Target 2025 | Achieved |
| 02.2.e. Number of countries and territories implementing strategies to increase access to responsive and quality health services for adolescents | Target 2025 | Achieved |
| 03.1.a. Number of countries and territories that implement comprehensive assessments of older persons at the first level of care | Baseline 2023 | Achieved |
| 07.1.a. Number of countries and territories that are implementing a national policy on human resources for health | Baseline 2023 | Achieved |
| 07.3.a. Number of countries and territories enabled to strengthen health workforce competencies and capacity-building programs through the Virtual Campus for Public Health and other WHO platforms | Baseline 2023 | Achieved |
| 08.1.a. Number of countries and territories with updated national policies and/or strategies on access, quality, and use of medicines and other health technologies | Baseline 2023 | Achieved |
| 08.2.a. Number of countries and territories that have established an institutional development plan to improve regulatory capacity for health products based on the assessment of their national regulatory capacities by the Global Benchmarking Tool | Target 2025 | Achieved |
| 08.4.a. Number of countries and territories implementing a national plan to strengthen access to radiological services and radiation safety | Target 2025 | Partially achieved |
| 08.5.a. Number of countries and territories implementing plans to manage and oversee the essential medicines supply chain, including planning, forecasting, and availability | Baseline 2023 | Achieved |
| 10.1.a. Number of countries and territories implementing equitable health financing strategies and reforms to sustain progress toward universal health, including specific strategies to progressively increase public expenditure in health in a sustainable manner | Target 2025 | Achieved |
| 10.1.b. Number of countries and territories implementing payment systems and resource allocation strategies to promote a PHC approach in the organization of health services delivery | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 04.1.a. Number of countries and territories implementing national norms, standards, and tools aligned with PAHO and WHO guidelines on TB, HIV, STIs, and VH, with emphasis on key and vulnerable populations | Target 2025 | Partially achieved |
| 04.2.a. Number of countries and territories implementing the new arboviral disease guidelines for patient care in the Region of the Americas | Baseline 2023 | Achieved |
| 12.1.a. Number of countries and territories that have campaigns on antimicrobial resistance and rational use aimed at the general public and at professional sectors | Baseline 2023 | Achieved |
| 12.3.a. Number of countries and territories with an established multisectoral coordinating mechanism to oversee national strategies to combat antimicrobial resistance | Baseline 2023 | Achieved |
| 12.4.a. Number of countries and territories that annually provide laboratory-based data on antimicrobial resistance | Baseline 2023 | Achieved |
| 12.7.a. Number of countries and territories that have in place or under implementation intersectoral mandatory risk-based regulatory mechanisms, food monitoring and foodborne disease surveillance systems, or any other practice to protect public health from foodborne diseases, with a One Health approach | Baseline 2023 | Achieved |
| 12.8.a. Number of countries and territories that have programs to prevent or mitigate zoonotic diseases and snake/arthropod envenoming | Baseline 2023 | Achieved |
| 12.9.a. Number of countries and territories with integrated territorial actions for prevention, control, and/or surveillance of vector-borne transmission of Trypanosoma cruzi | Baseline 2023 | Achieved |
| 17.1.a. Number of countries and territories implementing PAHO/WHO-recommended interventions in active foci and areas at risk of reestablishment of malaria | Baseline 2023 | Achieved |
| 17.3.a. Number of countries and territories that administer hepatitis B vaccine to newborns during the first 24 hours | Baseline 2023 | Achieved |
| 17.8.a. Number of countries and territories implementing plans of action to strengthen prevention, prophylaxis, surveillance, and control for the validation of the elimination of rabies transmitted by dogs | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 05.1.a. Number of countries and territories that are implementing evidence-based national guidelines/protocols/standards for the management of NCDs (i.e. cardiovascular disease, cancer, diabetes, and chronic respiratory disease) | Target 2025 | Partially achieved |
| 05.2.b. Number of countries and territories with implementation plans for population-based surveys developed with direct support from PASB | Target 2025 | Achieved |
| 05.3.a. Number of countries and territories with comprehensive mental health services integrated into primary health care in at least 50% of primary health care facilities | Baseline 2023 | Achieved |
| 05.4.a. Number of countries and territories that collect, analyze, and report a core set of mental health indicators within the national health information systems | Baseline 2023 | Achieved |
| 06.1.a. Number of countries and territories that have a single emergency care access number with full national coverage | Target 2025 | Partially achieved |
| 13.1.a. Number of countries and territories implementing population-based policy measures to reduce the harmful use of alcohol in line with PAHO and WHO resolutions | Target 2025 | Not achieved |
| 13.1.e. Number of countries and territories covered by best-practice policies to eliminate industrially produced trans-fatty acids in the food supply | Target 2025 | Not achieved |
| 14.1.a. Number of countries and territories that are implementing national policies consistent with the WHO Global Targets 2025 for maternal, infant, and young child nutrition and the nutrition components of the Sustainable Development Goals | Baseline 2023 | Achieved |
| 16.2.a. Number of countries and territories with national multisectoral strategies and plans aimed at the prevention of suicide across the life course and addressing its main risk factors and social determinants | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 18.2.b. Number of countries implementing plans, policies, programs, and/or interventions to increase climate resilience and environmental sustainability of health care waste management practices, following WHO Guidelines | Target 2025 | Achieved |
| 26.2.a. Number of countries and territories implementing policies, plans, and strategies to advance health equity | Baseline 2023 | Achieved |
| 26.4.a. Number of countries and territories implementing policies, plans, and programs to advance ethnic equality in health | Baseline 2023 | Achieved |
| 26.5.a. Number of countries and territories using human rights norms and standards in the formulation and implementation of health-related policies, plans, programs, and legislation | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 21.2.a. Number of countries and territories with mechanisms (policies, standards, tools, etc.) in place for the generation, dissemination, and preservation of, and access to, scientific and technical data, information, and evidence for health | Target 2025 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 23.1.a. Number of States Parties completing annual reporting on the International Health Regulations (2005) | Baseline 2023 | Achieved |
| 23.1.b. Number of countries and territories that have evaluated disaster and emergency preparedness capacities in the health sector | Baseline 2023 | Achieved |
| 23.2.a. Number of States Parties with national action plans developed for strengthening International Health Regulations (2005) core capacities | Target 2025 | Not achieved |
| 23.2.b. Number of countries and territories with full-time staff assigned to health emergencies | Target 2025 | Partially achieved |
| 23.3.a. Number of States Parties that have conducted simulation exercises or after-action review | Target 2025 | Not achieved |
| 23.4.a. Number of countries and territories that include safe hospital criteria in the planning, design, construction, and operation of health services | Baseline 2023 | Achieved |
| 23.5.a. Number of countries and territories that include criteria for disaster mitigation and climate change adaptation in the planning, design, construction, and operation of health services | Baseline 2023 | Achieved |
| 24.2.a. Number of countries and territories with strategies and/or plans in place to detect and respond to high-threat and emerging pathogens, including emerging zoonotic pathogens | Baseline 2023 | Achieved |
| 24.3.b. Number of countries and territories performing regular monitoring/auditing of infection prevention and control practices in referral care facilities | Baseline 2023 | Achieved |
| 24.3.c. Number of countries and territories with operational integrated surveillance systems and pandemic preparedness plans for respiratory viruses, including influenza and COVID-19 | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 27.1.a. Number of countries and territories with a current Country Cooperation Strategy | Baseline 2023 | Achieved |